Every patient’s cancer is unique. However, the vast majority of cancer patients are still treated as if cancers can be grouped together by the organ of origin (e.g., colon cancer, breast cancer) rather than by looking at each cancer on an individual basis. Personalized medicine considers the uniqueness of each cancer patient’s tumor, and uses […]
CureMatch takes fighting pediatric cancer seriously. Seeing kids suffering from cancer when modern technology and genomics could hold the cures is not the responsible thing to do. CureMatch has been working hard to provide this decision support system to clinicians, oncologists and pediatric cancer teams around the globe. In a bold move by co-founder Blaise […]
Many of these precision oncology findings have been incorporated into the intelligence of the CureMatch decision support platform. CHICAGO, IL – June 2, 2017 – UCSD oncologist and CureMatch Co-Founder Dr. Razelle Kurzrock and colleagues are presenting ground-breaking cancer discoveries on a variety of topics related to personalized cancer therapy at the American Society of Clinical Oncology […]
Xconomy National reporter Alex Lash reports on tumor sequencing and a new program in Maine to make genomics free to cancer patients. UCSD oncologist and CureMatch co-founder Dr. Razelle Kurzrock is featured and quoted in the article:
CureMatch makes it affordable for all to get personalized cancer treatment, and offers the decision support system service for free for children with cancer SAN DIEGO, CA – May 25, 2017 –CureMatch™ today announced the pricing for its Personalized Combination Therapy™ report. The report guides oncologists in the selection of cancer treatment options that are […]
